-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Ptc Therapeutics, Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2020 to Q1 2025.
- Ptc Therapeutics, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2025 was $7.22M, a 87% decline year-over-year.
- Ptc Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2024 was $75.7M, a 68% decline from 2023.
- Ptc Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2023 was $237M, a 83.6% increase from 2022.
- Ptc Therapeutics, Inc. annual Depreciation, Depletion and Amortization for 2022 was $129M, a 101% increase from 2021.
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)